Rapid analysis of fatty acid-binding proteins with immunosensors and immunotests for early monitoring of tissue injury

被引:37
作者
Chan, CPY
Wan, TSM
Watkins, KL
Pelsers, MMAL
Van der Voort, DL
Tang, FPW
Lam, KHK
Mill, J
Yuan, Y
Lehmann, M
Hempel, A
Sanderson, JE
Glatz, JFC
Renneberg, R [1 ]
机构
[1] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China
[2] Hong Kong Jockey Club, Racing Div, Hong Kong, Hong Kong, Peoples R China
[3] Maastricht Univ, CARIM, Dept Mol Genet, Maastricht, Netherlands
[4] Maastricht Univ, CARIM, Dept Biochem, Maastricht, Netherlands
[5] Racecourse Hoppegarten, Berlin, Germany
[6] Hong Kong Sports Dev Board, Sports Sci Dept, Sports Inst, Shatin, Hong Kong, Peoples R China
[7] 8sens Biognost AG, Berlin, Germany
[8] Ctr Heart, Dept Cardiol, Bernau, Germany
[9] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China
关键词
biochemical marker; brain injury; heart-type fatty acid-binding protein (H-FABP); immunoassay; immunosensor; immunotest; acute myocardial infarction (AMI); point-of-care testing (POCT); \skeletal muscle injury; tissue injury; thoroughbreds;
D O I
10.1016/j.bios.2004.09.028
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
Fatty acid-binding protein (FABP) holds promise for early detection of tissue injury. This small protein (15 kD) appears earlier in the blood than large proteins after cell damage. Combined its characteristics of high concentration tissue contents and low normal plasma values provide the possibility of a rapid rise above the respective reference values, and thus an early indication of the appearance of tissue injury. A general review was presented on the current status of different types of FABP for the detection of tissue injury in patients with myocardial injury, brain injury and also in athletes or horses with skeletal muscle injury. To take full advantage of the characteristics of the early marker FABP, rapid analysis is a crucial parameter. In this review, an overview of the development of immunoassay for the quantification of FABP in buffer, plasma or whole blood was outlined. The characteristics of different FABP immunosensors and immunotests were described. The feasibility of these immunoassays to be used in routine clinical practice and in emergency case was also discussed. Nowadays, the improved automated immunoassays (e.g. a microparticle-enhanced turbidimetric immunoassay), less time-consuming bedside immunosensors and immunotests (e.g. a one-step FABP lateral flow immunotest), are the main advance technology in point-of-care testing. With these point-of-care tests, the application of FABP as an early tissue injury marker has a great potential for many clinical purposes. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:2566 / 2580
页数:15
相关论文
共 69 条
[1]
Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]
DETERMINATION OF S-100 AND GLIAL FIBRILLARY ACIDIC PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID AFTER BRAIN INFARCTION [J].
AURELL, A ;
ROSENGREN, LE ;
KARLSSON, B ;
OLSSON, JE ;
ZBORNIKOVA, V ;
HAGLID, KG .
STROKE, 1991, 22 (10) :1254-1258
[3]
Management of acute coronary syndromes:: acute coronary syndromes without persistent ST segment elevation -: Recommendations of the Task Force of the European Society of Cardiology [J].
Bertrand, ME ;
Simoons, ML ;
Fox, KAA ;
Wallentin, LC ;
Hamm, CW ;
McFadden, E ;
De Feyter, PJ ;
Specchia, G ;
Ruzyllo, W .
EUROPEAN HEART JOURNAL, 2000, 21 (17) :1406-1432
[4]
Chan CPY, 2004, Z KARDIOL, V93, P388, DOI 10.1007/s00392-004-0080-6
[5]
Development of a quantitative lateral-flow assay for rapid detection of fatty acid-binding protein [J].
Chan, CPY ;
Sum, KW ;
Cheung, KY ;
Glatz, JFC ;
Sanderson, JE ;
Hempel, A ;
Lehmann, M ;
Renneberg, I ;
Renneberg, R .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 279 (1-2) :91-100
[6]
Early diagnosis of acute myocardial infarction using immunosensors and immunotests [J].
Chan, CPY ;
Cheng, WS ;
Glatz, JFC ;
van der Voort, D ;
Sanderson, JE ;
Hempel, A ;
Lehmann, M ;
Renneberg, I ;
Renneberg, R .
ANALYTICAL LETTERS, 2003, 36 (09) :1987-2004
[7]
Cheng S., 2000, THESIS HONG KONG U S, P171
[8]
CLARKSON PM, 1992, MED SCI SPORT EXER, V24, P512
[9]
MYOGLOBIN IS A SENSITIVE MARKER OF INCREASED MUSCLE MEMBRANE VULNERABILITY [J].
DRIESSENKLETTER, MF ;
AMELINK, GJ ;
BAR, PR ;
VANGIJN, J .
JOURNAL OF NEUROLOGY, 1990, 237 (04) :234-238
[10]
Use of colloidal gold surface plasmon resonance peak shift to infer affinity constants from the interactions between protein antigens and antibodies specific for single or multiple epitopes [J].
Englebienne, P .
ANALYST, 1998, 123 (07) :1599-1603